Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

v2.4.0.8
Acquisitions (Tables)
12 Months Ended
Jun. 30, 2014
Estimated Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as a result of the acquisitions (in thousands):

 

     Bionostics      PrimeGene  

Current assets

   $ 9,605       $ 1,272   

Intangible Assets

     60,500         14,622   

Goodwill

     56,349         5,518   

Equipment

     2,180         546   
  

 

 

    

 

 

 

Total assets acquired

     128,634         21,958   

Liabilities

     3,007         887   

Deferred income taxes

     22,478         2,310   
  

 

 

    

 

 

 

Net assets acquired

   $ 103,149       $ 18,761   
  

 

 

    

 

 

 

Cash paid, net of cash acquired

   $ 103,149       $ 6,031   

Note payable

     0         12,730   
  

 

 

    

 

 

 

Net purchase price

   $ 103,149       $ 18,761